SCHEMBL26019983

SCHEMBL26019983

Cc1ccc(Cc2cnc3n2CCNC3)c(C(F)(F)F)c1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2C P28335 3/20 0.33
HTR2B P41595 2/20 0.33
MKNK1 Q9BUB5 2/20 0.33
MKNK2 Q9HBH9 2/20 0.33
EPHX2 P34913 1/20 0.33
ADRB2 P07550 1/20 0.33
ADRA2A P08913 1/20 0.33
AXL P30530 1/20 0.33
HRH1 P35367 1/20 0.33
HTR6 P50406 1/20 0.33
GSK3B P49841 8/20 0.33
DYRK1A Q13627 8/20 0.33
WNT1 P04628 6/20 0.33
MELK Q14680 2/20 0.33
CSF1R P07333 1/20 0.33
YES1 P07947 1/20 0.33
RET P07949 1/20 0.33
FGFR1 P11362 1/20 0.33
FLT1 P17948 1/20 0.33
FLT4 P35916 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26019795 0.88 SLC6A2 (0.38) EPHX2GSK3BDYRK1AWNT1SLC6A2
SCHEMBL24176683 0.88 TACR1 (0.40) HTR2CEPHX2ADRB2GSK3BDYRK1A
SCHEMBL30603338 0.88 SLC6A2 (0.38) EPHX2GSK3BDYRK1AWNT1SLC6A2
Hydrochloric Acid SCHEMBL28682527 0.87 IDO1 (0.38) EPHX2GSK3BDYRK1AWNT1SLC6A2
SCHEMBL30866292 0.85 SLC6A2 (0.43) EPHX2NCF1CYP1A2CYP2C19SLC6A2
SCHEMBL24176694 0.85 SLC6A2 (0.43) EPHX2NCF1CYP1A2CYP2C19SLC6A2
SCHEMBL24176792 0.85 DDR1 (0.37) EPHX2GSK3BDYRK1AWNT1MELK
SCHEMBL24176754 0.82 SLC6A2 (0.38) HTR2CHTR2BEPHX2GSK3BDYRK1A
SCHEMBL29833333 0.78 SLC6A2 (0.40) EPHX2SLC6A2SLC6A4
SCHEMBL24177156 0.78 SLC6A2 (0.40) EPHX2SLC6A2SLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230257382-A1 HETEROCYCLIC COMPOUND AND USE THEREOF WUHAN LL SCIENCE AND TECHNOLOGY DEVELOPMENT CO., LTD. (CN) 2023-08-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230257382-A1 HETEROCYCLIC COMPOUND AND USE THEREOF TRPC5, TRPC1, GOT1 HTR2C 285/4885HTR2B 176/4885MKNK1 2359/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.